What Supplements Should I Take for MTHFR Mutation?

Methylfolate (also called 5-MTHF or L-methylfolate) is the supplement most directly relevant to an MTHFR mutation, because it is the active form of folate your body would normally produce with a fully functioning MTHFR enzyme. But the honest picture is broader than a single pill. Riboflavin, vitamins B12 and B6, and choline each play distinct roles in the same metabolic network, and the evidence for each varies depending on which variant you carry, how severely your enzyme is affected, and what you are trying to prevent. Meanwhile, the largest genetics professional organization in the United States has pushed back on routine MTHFR testing altogether, which creates a real tension between what people find in their direct-to-consumer results and what their doctors are willing to act on.

What an MTHFR Variant Actually Changes

MTHFR is an enzyme that converts one form of folate into its active form, 5-methyltetrahydrofolate. That active folate is needed to recycle homocysteine back into methionine, an amino acid your cells use to make proteins and to produce a key molecule called SAM that handles methylation reactions throughout the body.¹ When the enzyme works poorly, homocysteine tends to build up, and active folate levels drop.

The two most studied variants are C677T and A1298C. Being homozygous for C677T (having two copies of the T allele) reduces enzyme activity by roughly 70%. Being homozygous for A1298C cuts activity to about 60% of normal. And people who are heterozygous for both variants at the same time, roughly 15% of the population, end up with 50–60% of normal enzyme activity.² A single copy of either variant alone has a much milder effect, and many people with one copy never develop any measurable problem.

This matters for supplement decisions because the degree of enzyme impairment determines how much your homocysteine rises and how much help you actually need. Someone homozygous for C677T living in a country with mandatory folic acid fortification may still have mildly elevated homocysteine. Someone with one copy of A1298C and otherwise good nutrition may have completely normal levels and no reason to supplement at all.

Why Methylfolate Instead of Folic Acid

Folic acid is the synthetic form found in most fortified foods and cheap supplements. Your body has to convert it through several steps, one of which requires MTHFR, to get the active 5-MTHF form. If your MTHFR enzyme is sluggish, folic acid can pile up in your bloodstream as unmetabolized folic acid (UMFA). Accumulation of UMFA has been linked to masking of vitamin B12 deficiency, cognitive and psychiatric concerns, and adverse pregnancy outcomes in people with the C677T genotype.³

Animal research has reinforced this concern. In mice with reduced MTHFR function, a high-folic-acid diet caused liver cell damage. Six of seven mice with both the genetic variant and the high-folic-acid diet developed a specific type of liver cell deterioration, compared with at most one of seven in other groups.⁴ That is a dramatic difference, and while animal findings do not translate directly to humans, it is a plausible reason to prefer a form of folate that bypasses the bottleneck entirely.

Methylfolate (5-MTHF) skips the MTHFR conversion step. It is already the active compound your body needs for homocysteine recycling. It is available as a standalone supplement, usually labeled as L-methylfolate, and also appears in some prenatal vitamins marketed to women with known MTHFR variants. Typical supplemental doses range from 400 micrograms to 15 milligrams, though the higher doses are usually used in clinical settings for depression or pregnancy loss rather than general wellness.

There is also a third option: folinic acid (sometimes called leucovorin or 5-formyltetrahydrofolate), which enters the folate cycle at a different point and also does not require MTHFR to become active. One clinical trial comparing folinic acid and L-methylfolate in healthy adults found that both lowered homocysteine. Interestingly, people with the MTHFR 677CT genotype actually had a significantly larger homocysteine reduction with folinic acid than with L-methylfolate.⁵ This is worth knowing because the supplement industry has so strongly promoted methylfolate that folinic acid gets overlooked, even though it may work as well or better for some genotypes.

Riboflavin, the Supplement Most People Miss

The MTHFR enzyme does not work alone. It depends on a riboflavin-derived cofactor (FAD) to function. The C677T variant produces a version of the enzyme that loses its grip on this cofactor more easily, which is a large part of why enzyme activity drops in the first place.⁶ Supplying more riboflavin (vitamin B2) essentially gives the wobbly enzyme more chances to hold onto its cofactor and keep working.

This is one of the most underrated findings in MTHFR supplementation. A study published in Circulation showed that riboflavin supplementation lowered homocysteine specifically in people homozygous for C677T. The effect was genotype-specific: people without the variant did not see the same benefit. That kind of targeted response is unusual in nutrition research and suggests the mechanism is genuinely tied to the cofactor loss rather than some general B-vitamin effect. Riboflavin is cheap, widely available, and has essentially no toxicity risk at supplemental doses. If you carry two copies of C677T and are only taking methylfolate, adding riboflavin is one of the more evidence-backed moves you can make.

The Roles of B12 and B6

Vitamin B12 (cobalamin) is the other nutrient directly involved in converting homocysteine to methionine. The enzyme that performs this conversion, methionine synthase, requires both the active folate that MTHFR produces and a B12-derived cofactor. If B12 is low, even adequate folate will not fully clear homocysteine. B12 deficiency also traps folate in its methylated form, disrupting DNA synthesis and potentially compounding the effects of an MTHFR variant.⁷

Vitamin B6, meanwhile, works on a different branch of homocysteine metabolism called the transsulfuration pathway. Instead of recycling homocysteine back to methionine, this pathway converts it into cysteine and eventually disposes of it. A large population study found that the relationship between B6 levels and homocysteine was strongest in people with the MTHFR 677TT genotype, but only in the lowest range of B6 status.⁸ In practical terms, if you are already eating a reasonably balanced diet and your B6 status is not particularly low, adding extra B6 probably will not move the needle much. But if you are deficient in B6, fixing that deficiency becomes more important when your MTHFR-dependent pathway is also compromised.

A study of women with recurrent pregnancy loss and MTHFR mutations used a combination of methylfolate (5 mg/day), vitamin B6 (50 mg/day), and weekly vitamin B12 injections (1 mg/week). Homocysteine dropped from an average of about 19 to about 7 micromoles per liter, and seven of the sixteen women became pregnant and delivered within a year.⁹ That is a small study, but it illustrates why clinicians who do treat MTHFR variants tend to use a combination of supplements rather than methylfolate alone.

Choline and Betaine as an Alternative Route

Your body has a backup system for recycling homocysteine that does not depend on folate or MTHFR at all. An enzyme called BHMT can convert homocysteine to methionine using betaine, a molecule derived from dietary choline. Roughly half of the SAM produced in cells comes through this betaine-dependent pathway rather than the folate-dependent one.¹⁰

This has a practical implication: if you have an MTHFR variant that weakens the folate-dependent pathway, the choline-betaine pathway becomes proportionally more important for keeping homocysteine in check. Choline or betaine supplementation has been shown to significantly lower post-methionine-load homocysteine, whereas folate supplementation has a smaller effect on that specific measure.¹⁰ Most people do not get enough choline from diet alone, and those with MTHFR variants may have an even greater need for it. Egg yolks, liver, and soybeans are the richest food sources. Supplemental choline typically comes as choline bitartrate or phosphatidylcholine, and betaine (trimethylglycine) is available as a standalone supplement as well.

This pathway is not a replacement for folate. Both routes feed into the same end products, and folate has roles beyond homocysteine recycling, including nucleotide synthesis for DNA repair. But ensuring adequate choline gives your body a second lane on the highway when the first is partially blocked.

MTHFR and Pregnancy

Pregnancy is where MTHFR variants get the most clinical attention, because folate demand rises sharply and the consequences of deficiency are well established. Neural tube defects, recurrent miscarriage, and preeclampsia have all been linked to folate metabolism problems. In mouse models, mothers homozygous for the MTHFR 677T variant who were given low dietary folate had significantly more developmental delays in their offspring than those given adequate folate. This effect was specific to the TT genotype and did not appear in mothers without the variant.¹¹

For women with recurrent miscarriage who carry the C677T mutation, treatment approaches have included combinations of methylfolate, anticoagulants, and aspirin. One clinical comparison over five years found that low-dose aspirin combined with enoxaparin and folic acid was the most effective therapy for reducing miscarriage in these patients.¹² The involvement of anticoagulants here hints at the clotting-related aspects of high homocysteine, which goes beyond what supplements alone address.

There is also emerging evidence that the male partner’s MTHFR status matters for fertility. A case report described a couple with repeated miscarriages where the husband carried a triple MTHFR mutation. After three months of 5-MTHF supplementation along with nutritional support for the one-carbon cycle, the couple conceived and the pregnancy resulted in a healthy delivery. They went on to have a second healthy child three years later.¹³ A single case report is the weakest form of evidence, but it points toward a dimension of MTHFR that fertility specialists are beginning to explore: sperm quality and DNA integrity may also depend on adequate methylation.

What Medical Guidelines Say About MTHFR Testing

Here is where the gap between the supplement world and mainstream medicine becomes stark. The American College of Medical Genetics and Genomics (ACMG) published a practice guideline stating that there is a lack of evidence supporting routine MTHFR polymorphism testing.¹⁴ Their position is that MTHFR variants are common, that elevated homocysteine from these variants can generally be managed with standard folate and B-vitamin intake, and that knowing your MTHFR genotype rarely changes clinical management in a meaningful way.

This is not the same as saying the variants do not matter biologically. The ACMG argument is more pragmatic: since the treatment for mildly elevated homocysteine is the same regardless of whether it is caused by MTHFR variants, poor diet, or something else (namely, adequate B vitamins), testing for the gene does not add useful information in most cases. For someone already eating well and taking a B-vitamin supplement, a positive MTHFR result would not change the recommendation. And for someone with a poor diet and high homocysteine, the advice would be the same whether or not they had the variant.

Where this guideline creates friction is with patients who have already been tested through direct-to-consumer services and arrive at their doctor’s office alarmed. Some practitioners, especially in integrative and functional medicine, take a more interventionist approach and use MTHFR status to guide specific supplement protocols. The mainstream position is that checking homocysteine levels directly is more clinically useful than genotyping MTHFR, because homocysteine is the actual risk factor, and it can be elevated or normal regardless of genotype.

Homocysteine and Cardiovascular Risk

The reason homocysteine gets so much attention in the MTHFR conversation is its role in vascular damage. Elevated homocysteine is an independent risk factor for stroke and cardiovascular disease.¹⁵ Excess homocysteine contributes to damage through endothelial dysfunction, oxidative stress, and platelet activation, promoting clot formation in both arteries and veins.¹⁶

That said, the clinical trial data on whether lowering homocysteine with supplements actually prevents heart attacks and strokes has been surprisingly disappointing. Large randomized trials of B-vitamin supplementation to reduce cardiovascular events in high-risk patients have generally not shown the benefits researchers expected. This is one reason mainstream cardiology does not routinely recommend homocysteine-lowering therapy. The relationship between homocysteine and vascular disease is real, but it may be more of a marker than a direct lever. For people with MTHFR variants who have very high homocysteine levels, the rationale for supplementing is stronger than for those with levels in the mildly elevated range.

MTHFR and Mental Health

L-methylfolate has been studied as an add-on treatment for depression, particularly in patients who do not respond well to standard antidepressants. Folate is involved in producing neurotransmitters like serotonin, dopamine, and norepinephrine, so it makes biological sense that impaired folate metabolism could contribute to mood disorders. A case series of adolescents with treatment-resistant depression found that 80% had at least one MTHFR variant, and 80% showed improvement in depression, anxiety, and irritability after L-methylfolate was added to their existing antidepressant regimen.¹⁷

A case series is low-quality evidence by design, but L-methylfolate for depression does have a broader evidence base beyond MTHFR-specific populations. The FDA has cleared a prescription medical food form of L-methylfolate (sold as Deplin) for use alongside antidepressants. Whether its benefits are mediated specifically through MTHFR status or through a more general mechanism of improving folate availability to the brain remains an open question. If you are considering methylfolate for mood support, it is one of the more reasonable supplement-adjacent interventions, but it works best as an adjunct to, not a replacement for, standard psychiatric treatment.

Drug Interactions Worth Knowing About

Methotrexate, a drug used in cancer treatment and autoimmune diseases like rheumatoid arthritis, works by inhibiting folate metabolism. If you carry an MTHFR variant, your folate metabolism is already partially impaired, so methotrexate can hit harder. A meta-analysis of adults with blood cancers found that the MTHFR C677T polymorphism was significantly associated with increased liver toxicity, gastrointestinal toxicity, and mucositis from methotrexate.¹⁸

The picture is more mixed in children. A separate meta-analysis of MTHFR polymorphisms and methotrexate toxicity in children with acute lymphoblastic leukemia found no consistent association, and where associations were reported in individual studies, the results often contradicted each other.¹⁹ This age-related discrepancy is not fully explained but may relate to differences in drug dosing, organ maturity, or study design. If you are starting methotrexate and know you carry an MTHFR variant, it is worth mentioning to your prescribing physician, particularly if you are an adult. Many oncologists and rheumatologists already prescribe folinic acid alongside methotrexate to reduce side effects, which incidentally bypasses the MTHFR bottleneck.

Who Carries These Variants

MTHFR variants are not evenly distributed across populations. Research on U.S. primary care populations found striking differences in frequency by ethnicity. Hispanic Americans and Caucasians appear to be at elevated risk for MTHFR-related deficiency, with higher frequencies of the C677T and A1298C variants respectively. African Americans, by contrast, appear to be relatively protected, carrying these variants at lower rates.²⁰

These population differences have practical implications for public health. Countries with high C677T prevalence, including Mexico and parts of southern Europe, also tend to have higher baseline rates of neural tube defects and may benefit more from folic acid fortification programs. But the same fortification that helps the general population could contribute to UMFA accumulation in individuals whose MTHFR enzyme cannot process it efficiently. This tension between population-level benefits and individual-level risks is one reason the methylfolate-versus-folic-acid debate continues.

Putting a Supplement Stack Together

If you have confirmed MTHFR variants and elevated homocysteine, the evidence-informed approach involves several layers rather than a single supplement. The core is some form of active folate: either methylfolate or folinic acid, chosen based on your genotype and how you respond. Riboflavin is particularly important for C677T homozygotes, where the enzyme’s problem is partly about losing its cofactor. B12 and B6 round out the homocysteine pathways, with B12 being essential regardless of genotype and B6 being most important if your levels are low. And adequate choline, whether from diet or supplements, keeps the backup methylation pathway running.

What the evidence does not support is the elaborate, expensive protocols sometimes sold in the MTHFR supplement space. Multi-bottle regimens with proprietary methylation blends, high-dose SAMe, glutathione precursors marketed specifically for MTHFR, and stacked “methylation support” formulas often go well beyond what the research justifies. Regarding glutathione specifically, a study in mice with MTHFR deficiency found that glutathione levels in affected tissues were not significantly different from normal, likely because cells have alternative ways to acquire the building blocks for glutathione synthesis.²¹ The assumption that MTHFR variants deplete glutathione and therefore require glutathione supplementation is common in functional medicine circles but not well supported by the available data.

A reasonable starting point for someone with a confirmed variant and elevated homocysteine, developed with a physician, might look something like: methylfolate or folinic acid at a moderate dose, a B-complex that includes adequate B12, B6, and riboflavin, and dietary attention to choline-rich foods. Recheck homocysteine after two to three months to see if it has come down. If it has not, the doses or forms can be adjusted. If your homocysteine was never elevated in the first place, the argument for aggressive supplementation gets considerably weaker, regardless of what your genotype report says.